{"count": 3, "results": [{"_id": "34577590", "pmid": 34577590, "pmcid": "PMC8465337", "title": "Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment", "journal": "Pharmaceuticals (Basel)", "authors": ["Poor SR", "Ettcheto M", "Cano A", "Sanchez-Lopez E", "Manzine PR", "Olloquequi J", "Camins A", "Javan M"], "date": "2021-09-01T00:00:00Z", "doi": "10.3390/ph14090890", "meta_date_publication": "2021 Sep 1", "meta_volume": "14", "meta_issue": "9", "meta_pages": "", "score": 50268.426, "text_hl": "Consequently, @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@AD@@@ has been referred to \"@<m>DISEASE_Diabetes_Mellitus_Noninsulin_Dependent_3</m> @DISEASE_MESH:C566342 @@@type 3 diabetes@@@\" and antidiabetic medications such as intranasal @GENE_INS @GENE_3630 @@@insulin@@@, @CHEMICAL_Thiazolidinediones @CHEMICAL_MESH:D045162 @@@glitazones@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or liraglutide are being tested as possible alternatives. ", "citations": {"NLM": "Poor SR, Ettcheto M, Cano A, Sanchez-Lopez E, Manzine PR, Olloquequi J, Camins A, Javan M. Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment Pharmaceuticals (Basel). 2021 Sep 1;14(9):. PMID: 34577590", "BibTeX": "@article{34577590, title={Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment}, author={Poor SR and Ettcheto M and Cano A and Sanchez-Lopez E and Manzine PR and Olloquequi J and Camins A and Javan M}, journal={Pharmaceuticals (Basel)}, volume={14}, number={9}}"}}, {"_id": "38238285", "pmid": 38238285, "pmcid": "PMC10796941", "title": "Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer's model mice", "journal": "Transl Psychiatry", "authors": ["Cho SY", "Kim EW", "Park SJ", "Phillips BU", "Jeong J", "Kim H", "Heath CJ", "Kim D", "Jang Y", "López-Cruz L", "Saksida LM", "Bussey TJ", "Lee DY", "Kim E"], "date": "2024-01-18T00:00:00Z", "doi": "10.1038/s41398-024-02755-9", "meta_date_publication": "2024 Jan 18", "meta_volume": "14", "meta_issue": "1", "meta_pages": "34", "score": 50256.555, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, a primary anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ medication, has been anticipated to provide benefits for @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@Alzheimer's disease@@@ (@DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@AD@@@), also known as \"@<m>DISEASE_Diabetes_Mellitus_Noninsulin_Dependent_3</m> @DISEASE_MESH:C566342 @@@type 3 diabetes@@@\". ", "citations": {"NLM": "Cho SY, Kim EW, Park SJ, Phillips BU, Jeong J, Kim H, Heath CJ, Kim D, Jang Y, López-Cruz L, Saksida LM, Bussey TJ, Lee DY, Kim E. Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer's model mice Transl Psychiatry. 2024 Jan 18;14(1):34. PMID: 38238285", "BibTeX": "@article{38238285, title={Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer's model mice}, author={Cho SY and Kim EW and Park SJ and Phillips BU and Jeong J and Kim H and Heath CJ and Kim D and Jang Y and López-Cruz L and Saksida LM and Bussey TJ and Lee DY and Kim E}, journal={Transl Psychiatry}, volume={14}, number={1}, pages={34}}"}}, {"_id": "30298769", "pmid": 30298769, "title": "Comparator clinical trials of surrogate endpoints with albiglutide are in HARMONY.", "journal": "Expert Rev Endocrinol Metab", "authors": ["Doggrell SA"], "date": "2015-05-01T00:00:00Z", "doi": "10.1586/17446651.2015.995629", "meta_date_publication": "2015 May", "meta_volume": "10", "meta_issue": "3", "meta_pages": "273-276", "score": 50047.223, "text_hl": "HARMONY 3: 104-Week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, @CHEMICAL_Sitagliptin_Phosphate @CHEMICAL_MESH:D000068900 @@@sitagliptin@@@, and @CHEMICAL_glimepiride @CHEMICAL_MESH:C057619 @@@glimepiride@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Diabetes_Mellitus_Noninsulin_Dependent_3</m> @DISEASE_MESH:C566342 @@@type 3 diabetes@@@ taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Doggrell SA. Comparator clinical trials of surrogate endpoints with albiglutide are in HARMONY. Expert Rev Endocrinol Metab. 2015 May;10(3):273-276. PMID: 30298769", "BibTeX": "@article{30298769, title={Comparator clinical trials of surrogate endpoints with albiglutide are in HARMONY.}, author={Doggrell SA}, journal={Expert Rev Endocrinol Metab}, volume={10}, number={3}, pages={273-276}}"}}]}